NextCure, Inc. (NXTC) short interest & options flow
NASDAQNXTC heads into its May 11 earnings call with the stock already trading on partial information — Q1 results published after the bell Thursday showed EPS of -$1.87, beating the -$2.12 estimate, alongside a significant pipeline update. The clinical newsflow has been the dominant driver. On May 4, NextCure and partner Simcere Zaiming announced the initiation of the dose optimization…
- Market cap
- $27M
- Next earnings
- 12 Nov 2026
Key data as of 12 Nov 2026

NXTC news and analysis
RSSNo long-form analysis yet for NXTC. Pulse alerts and the live data picture are available on ORTEX.
Open NXTC on ORTEX →Want the live picture for NXTC?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for NXTC — free to start on ORTEX.
Sign up for free →Open NXTC on ORTEX